Meet The Team
Phanes Therapeutics' PT217 receives Orphan Drug Designation for small cell lung cancer from the FDA
Volcanics Venture awarded with "The Most Entrepreneur Friendly Investment Institution"
Phanes Therapeutics announces FDA IND clearance for PT199
Fourier Intelligence has received 400million in Series D funding led by SoftBank.
Volcanics Venture awarded with "Top100 Venture Capital Institutions in China "
Volcanics Venture won multiply awards
Fourier Intelligence Raises Tens of Millions in Series C+ Financing Round
RootPath raises $50m
Huleen, a note-taking mobile app, received the angel round funding from Volcanics Venture to further
Triastek Closes US$ 50 Million Series B Financing